High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R, Mayes MD, McDonagh KT, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Ryan K, Sunderhaus J, Russell K, Rambharose J, Storb R, Furst DE
Blood. 2002 100 (5): 1602-10

PMID: 12176878 · PMCID: PMC2956742

MeSH Terms (17)

Adult Antigens, CD34 Antilymphocyte Serum Combined Modality Therapy Cyclophosphamide Female Granulocyte Colony-Stimulating Factor Hematopoietic Stem Cell Mobilization Hematopoietic Stem Cell Transplantation Humans Immunosuppressive Agents Male Middle Aged Pilot Projects Scleroderma, Systemic Survival Analysis Transplantation, Autologous

Connections (1)

This publication is referenced by other Labnodes entities:

Links